How Will OpenAI’s Multi-Provider Strategy Affect NVIDIA?

Should the AI trade stand for “artificially inflated?” We discuss with Wedbush’s Dan Ives. Plus, Stempoint Capital’s Michelle Ross tells us what biotech names she is betting on right now. And, Sherry Paul from Morgan Stanley tells us how she is advising her clients with stocks at record highs.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.